Advances in hepatitis C treatment. Why aren’t they being used?
The really incredible advances in the treatment of hepatitis C bring to life several relevant questions as we move forward into 2015. First, who should be treating hepatitis C patients (primary care providers, gastroenterologists, infectious disease specialists)? Second, can we really afford to use these new treatments? I recently discussed this topic with my GI and hepatology colleagues in AGA Perspectives, the bi-monthly opinion magazine of the American …



![Understanding the hidden weight bias that harms patient care [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-4-190x100.jpg)


![Rebuilding the backbone of health care [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-3-190x100.jpg)
